Last updated: 11/03/2018 10:23:22

Estimation of the burden of rotavirus gastroenteritis (RV GE) in children less than 5 years in Greece

GSK study ID
109355
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: To estimate the burden of rotavirus gastroenteritis (RV GE) in children < 5 years of age in Greece
Trial description: The purpose of this study is to measure the disease burden from RV GE among children less than 5 years of age using hospital surveillance data. In addition, data collected will determine the seasonal distribution, disease severity, age distribution of RV GE. From an economic standpoint, the cost and impact of RV will also be assessed.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Estimation of the proportion of RV GE among all acute GE emergency room visits among children <5 years of age.

Timeframe: Approximately 12 months

Estimation of the proportion of RV GE among all acute GE hospitalisations among children <5 years of age.

Timeframe: Approximately 12 months

Estimation of the incidence of nosocomial RV GE among all hospitalised children <5 years of age.

Timeframe: Approximately 12 months

Secondary outcomes:

Determination of the age of the children, disease severity, and the seasonal distribution of RV GE among children <5 years of age.

Timeframe: Approximately 12 months

Assessing the costs related to the episodes of RV GE, by the completion of the Health Economic Questionnaire (interview with the parent for a subset of subjects) and the cost checklist provided by the hospital’s site staff.

Timeframe: Approximately 12 months

Identification of prevalent genotypes of RV among children <5 years of age.

Timeframe: Approximately 12 months

Interventions:
Procedure/surgery: Stool sample
Other: Data collection
Enrollment:
128
Observational study model:
Cohort
Primary completion date:
2010-05-03
Time perspective:
Prospective
Clinical publications:
Not applicable
Medical condition
Rotavirus gastroenteritis
Product
SB444563
Collaborators
Not applicable
Study date(s)
July 2008 to March 2010
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
Not applicable N/A - 5 years
Accepts healthy volunteers
No
  • A male or female child < 5 years of age at the time of the visit (a child becomes ineligible on the day of her/his 5th birthday).
  • Child is brought to the emergency room for acute GE during the study period or develop acute GE at least 48 hours after hospitalisation.
  • Not applicable.

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Thessaloniki, Greece, 546 38
Status
Study Complete
Location
GSK Investigational Site
Thessaloniki, Greece, 54636
Status
Study Complete
Location
GSK Investigational Site
Heraklion, Crete, Greece, 71409
Status
Study Complete
Location
GSK Investigational Site
Rio/Patras, Greece, 26500
Status
Study Complete
Location
GSK Investigational Site
Athens, Greece, 11527
Status
Study Complete
Location
GSK Investigational Site
Athens, Greece, 104 46
Status
Study Complete

Study documents

No study documents available.

Results overview

No study documents available

Recruitment status
Finalized
Actual primary completion date
2010-05-03
Actual study completion date
2010-05-03

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website